Ioanna Minopoulou

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.

Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.

Journal: EULAR rheumatology open

Published: August 01, 2026

Blinatumomab in refractory SLE-associated immune thrombocytopenia.

Blinatumomab in refractory SLE-associated immune thrombocytopenia.

Journal: Annals of the rheumatic diseases

Published: July 01, 2026

High acceptance and reported efficacy of cannabis for pain management in patients with rheumatic diseases in Germany: a postlegalisation survey.

High acceptance and reported efficacy of cannabis for pain management in patients with rheumatic diseases in Germany: a postlegalisation survey.

Journal: EULAR rheumatology open

Published: June 29, 2026

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

Journal: Nature medicine

Published: March 20, 2026

Effect of apremilast on entheseal bone damage in psoriasis patients at risk of developing psoriatic arthritis - data from the prospective, interventional EPOS study.

Effect of apremilast on entheseal bone damage in psoriasis patients at risk of developing psoriatic arthritis - data from the prospective, interventional EPOS study.

Journal: Arthritis research & therapy

Published: February 20, 2026

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.

Journal: Annals of the rheumatic diseases

Published: January 19, 2026

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.

Journal: Annals of the rheumatic diseases

Published: January 19, 2026

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Journal: Annals of the rheumatic diseases

Published: September 07, 2025

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values.

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values.

Journal: Annals of the rheumatic diseases

Published: May 30, 2025

Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index.

Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index.

Journal: Frontiers in medicine

Published: April 24, 2025

Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease.

Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease.

Journal: Autoimmunity reviews

Published: April 06, 2025

Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index.

Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index.

Journal: Frontiers in medicine

Published: February 10, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026